POC(Point-Of-Care) 혈당 측정 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Point-of-Care Glucose Testing Market size is expected to reach USD 6.50 Billion in 2034 from USD 4.09 Billion (2025) growing at a CAGR of 5.26% during 2026-2034.

The Global Point-of-Care Glucose Testing Market is witnessing significant growth driven by the rising prevalence of diabetes and increasing demand for rapid diagnostic solutions. Point-of-care devices enable immediate glucose monitoring, supporting timely clinical decisions and effective disease management. Growing awareness about self-monitoring and preventive healthcare is encouraging adoption among both hospital settings and home-care users.

Key growth drivers include technological advancements in portable glucose meters, continuous glucose monitoring systems, and smartphone-integrated testing devices. The expansion of telehealth services and remote patient monitoring has further boosted demand. Government initiatives promoting diabetes screening and management programs are also strengthening market expansion. Increasing geriatric population and sedentary lifestyles are contributing to the growing burden of diabetes worldwide.

In the future, integration of artificial intelligence and cloud-based data management systems is expected to enhance accuracy and connectivity of glucose testing devices. Emerging economies will provide substantial growth opportunities due to expanding healthcare access and rising health awareness. Continuous innovation aimed at improving convenience and affordability will support long-term adoption. As chronic disease management becomes a priority, the market is set for sustained and dynamic growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Lancing Devices and Strips
• Blood-Glucose Meter

By Application

• Type-1 Diabetes
• Type-2 Diabetes

By End User

• Hospitals and Clinics
• Home Care Settings
• Others

COMPANIES PROFILED

• Prodigy Diabetes Care LLC, Ascensia Diabetes Care Holdings AG, ACON Laboratories Inc, EKF Diagnostics Holdings plc, Trividia Health Inc, Platinum Equity Advisors LLC, Abbott Laboratories, Nipro, F HoffmannLa Roche Ltd, Nova Biomedical Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Lancing Devices and Strips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Blood-Glucose Meter Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Type-1 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type-2 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POINT-OF-CARE GLUCOSE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Prodigy Diabetes Care LLC
  • 9.2.2 Ascensia Diabetes Care Holdings AG
  • 9.2.3 ACON Laboratories Inc
  • 9.2.4 EKF Diagnostics Holdings Plc
  • 9.2.5 Trividia Health Inc
  • 9.2.6 Platinum Equity Advisors LLC
  • 9.2.7 Abbott Laboratories
  • 9.2.8 Nipro
  • 9.2.9 F. Hoffmann-La Roche Ltd
  • 9.2.10 Nova Biomedical Corporation